Skip to main content
Clinical Trials/IRCT201411127841N8
IRCT201411127841N8
Completed
未知

Efficacy of doluxetine add on conventional treatment in in?ammatory bowel disease patients, on depression, anxiety quality of life and severity of symptoms

Isfahan University of Medical Sciences, Psychosomatic Research Center0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Condition 1: In?ammatory bowel disease. Condition 2: In?ammatory bowel disease.
Sponsor
Isfahan University of Medical Sciences, Psychosomatic Research Center
Enrollment
40
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Isfahan University of Medical Sciences, Psychosomatic Research Center

Eligibility Criteria

Inclusion Criteria

  • 18\-65 years aged; current diagnosis of in?ammatory bowel disease; having no flair up of disease through past six months. Exclusion criteria: any serious medical condition that may interfere with safe study participation; current lactation, pregnancy or inadequate contraception; current serious suicidal intention or plan; lifetime bipolar, psychotic, or obsessive\-compulsive disorder; substance use disorders, major depressive disorder or anxiety disorders in the past 6 months; treatment with any psychotropic medication within seven days (or ?ve medication half\-lives) of beginning of study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials